ICLRNasdaqServices-Commercial Physical & Biological Research

ICON PLC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 27, 2026

$168.14−2.04 (-1.20%)

Close on Oct 19, 2026

Market cap: $13.01B
P/E (TTM): 300.2
Dividend yield: –

ICON PLC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Revenue	8,251	8,189	8,055	7,741	5,481	2,797	2,806	2,596	1,758	1,666	1,575	1,503	1,336	1,115	946	900	888	865
Cost of Revenue	6,076	5,818	5,706	5,527	3,973	1,980	1,974	1,818	1,027	961	909	903	845	718	612	541	508	489
Gross Profit	2,176	2,371	2,349	2,214	1,508	817	832	778	731	705	666	600	491	397	334	359	380	376
Selling, General & Admin	780	728	769	779	585	342	333	326	324	326	327	336	314	281	256	233	231	249
Advertising Expenses	–	–	–	–	–	7.02	8.09	6.52	6.74	7.17	4.51	3.56	5.20	3.68	2.91	3.43	2.55	–
Total Costs & Expenses	7,808	7,157	7,150	6,946	5,102	2,406	2,372	2,222	1,420	1,355	1,293	1,301	1,215	1,047	916	808	780	766
Operating Income	443	1,032	905	795	379	392	433	373	338	312	282	202	121	68	29	92	107	100
Interest Expense	197	237	337	230	182	13	13	14	13	13	3.99	0.79	1.29	1.95	1.64	1.13	3.53	4.11
Interest & Investment Income	7.11	8.61	5.01	2.35	0.57	2.72	6.86	4.76	2.35	1.48	1.31	1.15	0.99	1.15	1.19	1.76	0.75	2.88
Income from Equity Investments	0	0	-0.38	-3.14	-2.16	-0.37	0	0	–	–	–	–	–	–	–	–	–	–
Merger & Restructuring Charges	75	76	37	31	31	18	0	12	7.75	8.16	0	8.80	9.03	4.53	9.82	–	13	–
Asset Impairment Charges	364	0	0	0	20	5.41	0	0	0	0	0	5.63	0	0	0	0	0	–
Gain (Loss) on Investments	14	-3.30	0.20	–	0	0.23	0.06	0.06	0.11	0.05	-0.11	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	-0.14	-0.35	-0.07	-0.23	-0.15	-0.06	-0.25	-0.66	-0.23	-0.14	-0.14	-0.26	-0.25
Pretax Income	252	804	573	568	197	381	427	365	328	300	279	203	121	67	29	93	105	98
Income Tax Expense	23	65	18	59	41	48	51	42	47	38	39	30	18	12	6.12	5.65	10	20
Net Income incl. Noncontrolling Interests	229	739	554	505	153	333	376	323	281	–	–	–	–	–	–	–	–	–
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.19
Net Income	229	739	554	505	153	332	374	323	281	262	240	172	103	55	23	87	94	78
Net Income to Common	–	–	–	505	153	328	369	323	281	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	2.92	8.96	6.75	6.20	2.28	6.20	6.85	5.96	5.20	4.75	4.08	2.80	1.69	0.92	0.38	1.46	1.61	1.34
EPS (Diluted)(per share)	2.90	8.90	6.70	6.13	2.25	6.15	6.79	5.89	5.13	4.65	3.97	2.73	1.65	0.92	0.37	1.44	1.57	1.30
Shares Outstanding (Basic, Weighted)(shares)	78	82	82	82	67	53	54	54	54	55	59	61	61	60	60	60	59	58
Shares Outstanding (Diluted, Weighted)(shares)	79	83	83	82	68	53	54	55	55	56	60	63	62	60	61	61	60	58
EBITDA	826	1,521	1,491	1,365	694	458	495	439	400	371	339	255	168	111	68	126	140	127

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 23.9%
Operating margin: 3.6%
Net margin: 0.5%
Return on equity, FY2025: 2.5%

Financial strength

Current ratio: 0.95
Debt to equity: 0.23
Debt to assets: 12.9%
Cash to current liabilities: 23.6%

Valuation

P/E ratio: 300.2
Price to sales: 1.57
Price to book: 1.39
Dividend yield: –